Everest Medicines Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	12,980	15,592	6,698	5,375	10,326	19,851
Market Cap Growth	9.32%	132.78%	24.63%	-47.95%	-47.98%	-
Enterprise Value	12,048	13,630	4,306	3,712	6,099	22,544
Last Close Price	36.74	48.40	20.90	17.38	34.80	67.70
PS Ratio	13.91	20.73	48.28	371.66	155778.93	-
PB Ratio	3.02	3.60	1.22	0.84	1.43	2.44
P/TBV Ratio	7.03	8.06	2.49	1.45	2.46	3.46
EV/Sales Ratio	12.92	18.12	31.04	256.65	92015.48	-
Debt / Equity Ratio	0.19	0.14	0.11	0.10	0.09	0.07
Net Debt / Equity Ratio	-0.22	-0.25	-0.36	-0.20	-0.36	-0.59
Net Debt / EBITDA Ratio	1.43	1.53	2.28	0.80	2.04	5.88
Net Debt / FCF Ratio	1.75	1.38	2.04	0.74	2.53	8.36
Asset Turnover	-	0.13	0.02	0.00	0	-
Inventory Turnover	-	10.77	2.25	0.77	-	-
Quick Ratio	5.36	2.51	7.55	3.84	9.84	24.04
Current Ratio	5.46	2.54	7.63	3.92	9.95	24.06
Return on Equity (ROE)	-	-23.04%	-15.90%	-4.28%	-15.84%	-189.24%
Return on Assets (ROA)	-	-9.09%	-8.59%	-13.24%	-9.29%	-8.94%
Return on Capital Employed (ROCE)	-15.90%	-18.70%	-15.60%	-24.50%	-16.50%	-9.40%
Earnings Yield	-5.56%	-7.11%	-13.89%	-5.20%	-11.99%	-33.85%
FCF Yield	-4.12%	-5.08%	-14.58%	-31.80%	-9.98%	-2.88%
Buyback Yield / Dilution	-0.25%	-2.51%	-5.18%	-1.49%	-243.61%	-1532.82%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.